MedicarePartD.guide

A non-government resource built from CMS public data

NYVEPRIA 6 mg/.6mL Injection, Solution

Also known as Pegfilgrastim-Apgf. Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

3 of 11 stand-alone Part D plans in Connecticut, Massachusetts, Rhode Island and Vermont cover this drug on tier 5.

3 of 3 plans apply a prior authorization, step therapy or quantity limit.

8 Medicare Advantage plans in CT do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 8 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Wellcare Value Script (PDP)$16.40/mo premium · $615.00 deductible5Specialty Tier25%—$5760.2035—
  • Prior authorization
Wellcare Classic (PDP)$21.70/mo premium · $615.00 deductible5Specialty Tier25%—$5760.2035—
  • Prior authorization
HealthSpring Assurance Rx (PDP)$139.30/mo premium · $615.00 deductible5Specialty Tier25%—$5828.0230—
  • Prior authorization

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →